Rheumnow Podcast cover art

All Episodes

Rheumnow Podcast — 47 episodes

#
Title
1

Chikungunya Club Meeting (7.24.2026)

2

Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.)

3

Seronegative RA Disease Activity (7.17.2026)

4

What Lies Beneath - Uric Acid Deposition & Imaging

5

Gout QD clinics - lessons from the Clinic QD307-QD311

6

Gout Cavalcade (7.10.2026)

7

Gout Journal Club

8

Podcast Replay: Is it Time to Transition MOAs in RA?

9

ICYMI: Great Lectures; Great Presentations

10

Generic Tofacitinib (6.26.2026)

11

DERM on RheumNow (June 2026)

12

Do You Zoster Vaccinate? (6.19.2026)

13

RheumNow EULAR 2026 Rheumatology Round Up

14

EULAR 2026 RA Topic Panel

15

CAR-T Topic Panel EULAR 2026

16

EULAR 2026 PsA Update What's Changing in Psoriatic Arthritis Care?

17

RA Topic Podcast compilation

18

PsA Topic Podcast compilation

19

CAR T Topic compilation

20

EULAR 2026 Daily Podcast Day 4c

21

EULAR 2026 Daily Podcast Day 4b

22

EULAR 2026 Daily Podcast Day 4a

23

Day 4 Recap EULAR 2026

24

EULAR 2026 Daily Podcast Day 3a

25

Day 3 Recap EULAR 2026

26

EULAR 2026 Daily Podcast Day 2c

27

EULAR 2026 Daily Podcast Day 2b

28

Daily Recap Day 1 + 2 EULAR 2026

29

EULAR 2026 Daily Podcast Day 2a

30

EULAR 2026 Daily Podcast Day 1a

31

Count Your Telangiectasias (5.29.2026)

32

Quiz Talk (5.22.2026)

33

Infectious Rheumatology (5.15.2026)

34

Influential Rheumatoid Factors(5/8/2026)

35

Great Lectures; Great Presentations

36

DERM on RheumNow (April 2026)

37

Dead Words Eulogy

38

EULAR Daily Recap: Day 3

39

Depression and Anxiety Associated with Inability to Achieve Remission in RA and PsA

40

Cognitive Function in Older Adults with Lupus

41

Has JAK POT Hit the Spot About Infection Risk?

42

Top 3 Messages About JAK Inhibitor Safety

43

Pain in RA: Different Drugs for Different Mechanisms

44

JAK Inhibitors for New Indications

45

JAK Inhibitors for New Indications

46

Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?

47

Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?